title: Drug shortages in developed countries--reasons, therapeutic consequences, and handling.
abstract: Drug shortages in developed countries pose a serious public health problem and have far-reaching implications for healthcare providers and their patients. Given the current state of the market, with the limited number of manufacturers and the array of manufacturing quality issues, drug shortages have become a global concern, forcing regulatory authorities to explore and implement strategies to prevent and mitigate drug shortages.
authors.affiliation: US Food and Drug Administration, Silver Spring, MD, USA, susie.dill@fda.hhs.gov.
authors.forename: Susie
authors.initials: S
authors.lastname: Dill
authors.forename: Jin
authors.initials: J
authors.lastname: Ahn
mesh_terms: D002170:Canada; D019049:Developed Countries; D004345:Drug Industry; D004358:Drug Therapy; D005062:European Union; D006801:Humans; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*
chemical_list: D004364:Pharmaceutical Preparations